Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
M.D. Anderson Cancer Center
University of Nebraska
Weill Medical College of Cornell University
National Institutes of Health Clinical Center (CC)
AIDS Malignancy Consortium
City of Hope Medical Center
University of Maryland, Baltimore
St. Jude Children's Research Hospital
Massachusetts General Hospital
Barbara Ann Karmanos Cancer Institute
University of California, San Francisco
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)